Maria J. Guerra
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Serum angiotensin type-1 receptor autoantibodies and neurofilament light chain as markers of neuroaxonal damage in post-COVID patients.
Journal: Frontiers in immunology
Published: February 04, 2025
Modulation of Mitochondrial Dynamics by the Angiotensin System in Dopaminergic Neurons and Microglia.
Journal: Aging and disease
Published: August 12, 2024
The role of the brain renin-angiotensin system in Parkinson´s disease.
Journal: Translational neurodegeneration
Published: December 13, 2023
Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia.
Journal: Antioxidants (Basel, Switzerland)
Published: June 07, 2023
Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: August 01, 2018
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.
Journal: Molecular neurobiology
Published: November 18, 2017
Aging-related dysregulation in enteric dopamine and angiotensin system interactions: implications for gastrointestinal dysfunction in the elderly.
Journal: Oncotarget
Published: August 15, 2017
Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.
Journal: Frontiers in aging neuroscience
Published: February 21, 2017
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures.
Journal: Brain, behavior, and immunity
Published: November 27, 2016
Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration.
Journal: Frontiers in neuroendocrinology
Published: July 30, 2016
Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.
Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
Published: October 18, 2014
Last Updated: 09/26/2026